Stockholm3 blood test detected 90% of aggressive prostate cancer cases compared to 74% for PSA tests in a study of over ...

A new study suggests the investigational Stockholm3 blood test may improve the early detection of aggressive prostate cancer ...

NEW YORK (Reuters Health) - Most older men with prostate cancer found by prostate-specific antigen (PSA) tests and biopsies opted for treatment in a new study - even if signs pointed to their disease ...

A large analysis suggests that a multivariable risk assessment tool, called Stockholm3, can detect substantially more ...

The major challenge in prostate cancer screening is not just to find more cancer cases, but to identify the cancers that are ...

DEAR DR. ROACH: I am a 53-year-old healthy male, and I always request to check my PSA levels each year. My 57-year-old brother’s new doctor denied his request for a routine PSA check on their initial ...

State-funded clinical study will validate the OTraces’ proteomic blood test ability to reduce unnecessary prostate biopsies in men with elevated PSADEERFIELD BEACH, Fla. (GLOBE NEWSWIRE) -- OTraces, ...

Opportunistic prostate cancer screening can lead to overdiagnosis of indolent diseases and invasive procedures. A cohort study suggested that a low baseline PSA level in midlife was associated with a ...

ATLANTA - Each year, millions of American men get a blood test known as a PSA, or prostate-specific antigen, test as part of their yearly checkup. PSA is a protein produced by the prostate gland. If a ...

A next-generation Stockholm3 blood test detected aggressive prostate cancer more accurately than PSA, improving early ...